From: Erratum: Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients
Characteristic | Number of patients |
---|---|
Gender | |
Male | 14 |
Female | 4 |
Median age, years | 57.5 |
Age range, years | 45.1–80.6 |
Tumor site | |
Larynx | 5 |
Oropharynx | 3 |
Mouth floor | 2 |
Tongue | 2 |
Hypopharynx | 1 |
Maxilla | 1 |
Nasopharynx | 1 |
Sinuses | 1 |
Soft palate | 2 |
T-Stage | |
I | 4 |
II | 3 |
III | 5 |
IV | 6 |
N-Stage | |
N0 | 3 |
N1 | 4 |
N2 | 11 |
M-Stage | |
M0 | 17 |
M1 | 1 |
Concomitant therapy (in addition to radiotherapy) | |
5-FU + MMC | 13 (patient 2, 3, 5–7, 9–13, 15–17) |
MMC | 3 (patient 1, 14, 18) |
Cisplatin | 1 (patient 8) |
Cetuximab | 1 (patient 4) |
Acute toxicity | |
Severe | 12 |
Moderate | 5 |
n.a. | 1 |